3.5499
price down icon1.71%   -0.0618
after-market After Hours: 3.55 0.000100 +0.00%
loading
Evoke Pharma Inc stock is traded at $3.5499, with a volume of 3,082. It is down -1.71% in the last 24 hours and up +31.97% over the past month. Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
See More
Previous Close:
$3.6117
Open:
$3.5
24h Volume:
3,082
Relative Volume:
0.16
Market Cap:
$5.29M
Revenue:
$8.62M
Net Income/Loss:
$-6.15M
P/E Ratio:
-0.3218
EPS:
-11.03
Net Cash Flow:
$-5.32M
1W Performance:
-5.59%
1M Performance:
+31.97%
6M Performance:
-19.87%
1Y Performance:
-31.36%
1-Day Range:
Value
$3.33
$3.5499
1-Week Range:
Value
$3.33
$3.92
52-Week Range:
Value
$1.94
$12.32

Evoke Pharma Inc Stock (EVOK) Company Profile

Name
Name
Evoke Pharma Inc
Name
Phone
858-345-1494
Name
Address
420 STEVENS AVENUE, SOLANA BEACH, CA
Name
Employee
3
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
EVOK's Discussions on Twitter

Compare EVOK with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
EVOK
Evoke Pharma Inc
3.5499 5.61M 8.62M -6.15M -5.32M -11.03
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.35 50.14B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
168.63 72.38B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.79 4.22M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 45.51B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.78 19.45B 16.54B -1.64B 749.00M -1.45

Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-22-20 Upgrade H.C. Wainwright Neutral → Buy
Mar-05-19 Downgrade H.C. Wainwright Buy → Neutral
Mar-08-18 Reiterated B. Riley FBR, Inc. Buy
Oct-19-17 Resumed FBR & Co. Buy
Mar-16-17 Reiterated Rodman & Renshaw Buy
Jan-30-17 Upgrade Laidlaw Neutral → Buy
Jan-05-17 Upgrade Rodman & Renshaw Neutral → Buy
Dec-23-16 Reiterated Rodman & Renshaw Neutral
Jul-19-16 Reiterated FBR Capital Outperform
Jul-19-16 Downgrade Noble Financial Buy → Hold
Jul-18-16 Downgrade Rodman & Renshaw Buy → Neutral
Mar-16-16 Initiated Northland Capital Outperform
Mar-14-16 Reiterated Ascendiant Capital Markets Buy
Feb-17-16 Resumed FBR Capital Outperform
Dec-03-14 Reiterated MLV & Co Buy
Nov-07-14 Initiated MLV & Co Buy
Apr-22-14 Initiated Laidlaw Buy
Nov-19-13 Initiated Aegis Capital Buy
View All

Evoke Pharma Inc Stock (EVOK) Latest News

pulisher
May 27, 2025

Geriatric Medicines Market Expands Globally with Aging - openPR.com

May 27, 2025
pulisher
May 26, 2025

Diabetic Gastroparesis Treatment Market Size, Trends & - openPR.com

May 26, 2025
pulisher
May 23, 2025

Global Geriatric Medicines Market Generated Opportunities, - openPR.com

May 23, 2025
pulisher
May 22, 2025

Diabetic Gastroparesis Treatment Market in 2025-2032 Detailed - openPR.com

May 22, 2025
pulisher
May 15, 2025

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com - Defense World

May 15, 2025
pulisher
May 15, 2025

Barclays PLC Makes New $122,000 Investment in Innovator Equity Defined Protection ETF – 2 Yr to July 2026 (BATS:AJUL) - Defense World

May 15, 2025
pulisher
May 15, 2025

Raymond James Financial Inc. Takes Position in Metalla Royalty & Streaming Ltd. (NYSEMKT:MTA) - Defense World

May 15, 2025
pulisher
May 15, 2025

Barclays PLC Boosts Stock Holdings in Sunrise Realty Trust, Inc. (NASDAQ:SUNS) - Defense World

May 15, 2025
pulisher
May 15, 2025

Evoke Pharma Reports Strong Q1 2025 Sales Growth - TipRanks

May 15, 2025
pulisher
May 14, 2025

Evoke Pharma Reports First Quarter 2025 Financial Results and Pr - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Evoke Pharma, Inc. Q1 Loss Decreases, But Misses Estimates - Nasdaq

May 13, 2025
pulisher
May 13, 2025

Evoke Pharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

Evoke Pharma Q1 Operating Expenses USD 4.4 Million - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 13, 2025
pulisher
May 13, 2025

Evoke Pharma Reports 77% Increase in Q1 2025 Net Product Sales, Driven by GIMOTI Adoption and Provider Engagement - Nasdaq

May 13, 2025
pulisher
May 11, 2025

Evoke Pharma (EVOK) to Release Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 07, 2025

Evoke Pharma (NASDAQ:EVOK) Now Covered by Analysts at StockNews.com - Defense World

May 07, 2025
pulisher
Apr 29, 2025

StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World

Apr 29, 2025
pulisher
Apr 28, 2025

Evoke Pharma (EVOK) to Present Key Metoclopramide Study at DDW 2025 | EVOK Stock News - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Evoke Pharma to Present New Data Comparing Tardive Dyskinesia In - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Evoke Pharma Announces Presentation of New Research on Tardive Dyskinesia at Digestive Disease Week 2025 - Nasdaq

Apr 28, 2025
pulisher
Apr 28, 2025

Hudbay Signs Exploration Agreement with the Mosakahiken Cree Nation for the Talbot Deposit in Manitoba - The Manila Times

Apr 28, 2025
pulisher
Apr 28, 2025

Evoke Pharma to Present New Data Comparing Tardive - GlobeNewswire

Apr 28, 2025
pulisher
Apr 28, 2025

Groundbreaking Safety Analysis: How 100M+ Patient Study Could Reshape Metoclopramide Treatment Guidelines - Stock Titan

Apr 28, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 25, 2025

Functional Dyspepsia Drug Industry Report 2025-2034: Market Dynamics, Trends, and Forecasts - WhaTech

Apr 25, 2025
pulisher
Apr 19, 2025

Evoke Pharma, Inc. (NASDAQ:EVOK) Short Interest Update - Defense World

Apr 19, 2025
pulisher
Apr 19, 2025

FY2025 Earnings Estimate for TSE:MNO Issued By Cormark - Defense World

Apr 19, 2025
pulisher
Apr 17, 2025

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - Yahoo Finance

Apr 17, 2025
pulisher
Apr 15, 2025

Top Market Trend Impacting Digestive and Intestinal Remedies Development in the Coming Years:Technological ... - WhaTech

Apr 15, 2025
pulisher
Apr 09, 2025

Evoke Pharma stock hits 52-week low at $2.01 amid downturn By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

Evoke Pharma stock hits 52-week low at $2.01 amid downturn - Investing.com India

Apr 09, 2025
pulisher
Apr 07, 2025

Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2024 Earnings Call Transcript - MSN

Apr 07, 2025
pulisher
Apr 05, 2025

StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

US Reciprocal Tariffs Evoke Mixed Response From India Inc - Free Press Journal

Apr 04, 2025
pulisher
Apr 04, 2025

Is The Market Punishing Lynch Group Holdings Limited (ASX:LGL) For Its Mixed Fundamentals? - AInvest

Apr 04, 2025
pulisher
Apr 03, 2025

Gastroparesis Market Growth to Accelerate in Forecast Period - openPR.com

Apr 03, 2025
pulisher
Apr 02, 2025

Evoke Pharma stock hits 52-week low at $2.43 amid challenges By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

Evoke Pharma stock hits 52-week low at $2.43 amid challenges - Investing.com India

Apr 02, 2025
pulisher
Apr 01, 2025

Short Interest in Evoke Pharma, Inc. (NASDAQ:EVOK) Declines By 32.7% - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

Tenaz Energy Corp. (OTCMKTS:ATUUF) Short Interest Update - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Mar 31, 2025
pulisher
Mar 28, 2025

Evoke Pharma (NASDAQ:EVOK) Shares Cross Below 200 Day Moving Average – Here’s Why - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Evoke Pharma (NASDAQ:EVOK) Coverage Initiated at StockNews.com - Defense World

Mar 28, 2025
pulisher
Mar 25, 2025

Bleichroeder LP Significantly Reduces Stake in Evoke Pharma Inc - GuruFocus

Mar 25, 2025

Evoke Pharma Inc Stock (EVOK) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_specialty_generic RGC
$877.00
price up icon 18.36%
drug_manufacturers_specialty_generic HCM
$13.89
price up icon 0.22%
$123.02
price down icon 0.52%
drug_manufacturers_specialty_generic RDY
$14.72
price down icon 0.20%
$318.85
price down icon 0.47%
$16.78
price down icon 4.28%
Cap:     |  Volume (24h):